Injectable HIV Treatment: Long-Acting Cabenuva

Injectable HIV treatment means taking long-acting shots instead of daily pills to control HIV. The approach uses two medicines given by a clinician on a set schedule rather than tablets swallowed every day. It's for people already living with HIV who are virally suppressed. That's different from injectable PrEP, which prevents HIV in people who don't have it.

What injectable HIV treatment is — and isn't

HIV is a virus that attacks the immune system, and once a person has it, they have it for life CDC, About HIV. There's no cure, but antiretroviral therapy, or ART, drives the amount of virus in the blood down to undetectable levels, which keeps people healthy and stops onward transmission. Everyone diagnosed with HIV should start ART as soon as possible and stay on it for life, aiming for an undetectable viral load.

ART is always a combination of medicines from different drug classes — integrase inhibitors, NRTIs, NNRTIs, and protease inhibitors CDC, HIV Treatment. For most of the history of HIV care, that combination came as pills, often a single daily tablet. Long-acting injectable ART packages a combination into shots a clinician administers on a fixed schedule, so the medicine works without a daily reminder. This article is about controlling existing HIV. If you don't have HIV and want the injectable shot that prevents it, that's PrEP, a different product with a different purpose CDC, PrEP.

How injectable HIV treatment works

Injectable ART is built on the same principle as oral ART: combine medicines from more than one class so the virus can't replicate. The injectable approach uses long-acting formulations of integrase-inhibitor and NNRTI medicines that stay active in the body for weeks after a single injection, which is what makes a non-daily schedule possible.

Because the source guidance here doesn't list a specific milligram dose or a fixed week-count for treatment injections, I'll describe what's consistent across long-acting HIV care rather than guess a number. Treatment shots are given by a healthcare provider, not self-injected at home, usually as two injections at the same visit, on a recurring schedule your clinic sets. Most people start injectable treatment only after their virus is already undetectable on pills, because the suppression has to be in place first. Some clinics use a short lead-in of oral medicine to confirm you tolerate the drugs before switching to the long-acting version.

The benchmark for success is the same whichever form you use: an undetectable viral load. Most people reach undetectable within the first several months of starting effective ART CDC, Treatment as Prevention. Reaching and holding that mark makes the medicine work as both treatment and prevention.

What injectable treatment is actually like

The biggest practical difference from pills is that you trade a daily habit for scheduled clinic visits. People who struggle to take a tablet every day — because of routine, stigma at home, or pill fatigue — often find the shots easier to stay on. The trade-off is that you have to show up for each appointment on time. The schedule isn't flexible, because the drug level falls predictably between doses.

The injections go into the muscle, typically the buttock, and the most common experience afterward is an injection-site reaction — soreness, swelling, or a firm lump at the spot — that usually settles on its own. Plan for a few minutes of discomfort and the occasional ache the next day rather than a serious side effect. Some people treat the next visit as optional once they feel fine. With long-acting medicine, a missed or very late dose can let the drug level drop enough to risk resistance, so clinics take scheduling seriously and often offer a short grace window with a backup oral plan.

Cost and access depend heavily on insurance and which clinic you use. If you're earlier in the process and not yet in care, starting treatment sooner protects your own health and helps prevention at the same time — see earlier hiv treatment can help prevention.

What this means for partners

Treatment is also the strongest prevention tool you have for the people you're intimate with. Undetectable equals untransmittable — U=U — means a person who takes HIV medicine as prescribed and stays virally suppressed will not pass HIV to sex partners aidsmap, U=U. This comes from trial data. Across the PARTNER studies, mixed-status couples logged tens of thousands of condomless sex acts and recorded zero linked transmissions while the partner with HIV was undetectable, defined as under 200 copies/mL PARTNER study.

Injectable ART delivers U=U the same way pills do, as long as you stay on schedule and suppressed. If a partner doesn't have HIV and wants their own protection, PrEP — daily pills or the every-two-month injectable — reduces HIV risk from sex by about 99% when taken as prescribed. Partners who want clarity on timing after any possible exposure can read when to test after exposure.

Follow-up and monitoring

There's no "test-of-cure" for HIV, because HIV is controlled rather than cured. What replaces it is ongoing viral-load monitoring. Your clinician checks your viral load with blood tests to confirm you've reached undetectable and stayed there, and tracks your CD4 count, the immune cell HIV attacks, to confirm your immune system is recovering.

On injectable treatment, your follow-up visits double as both your dose appointments and your monitoring. An undetectable result doesn't mean the virus is gone — latent HIV reservoirs persist in cells and tissue, and the virus rebounds if treatment stops HHS clinicalinfo. ART is lifelong, and keeping every appointment matters even when you feel completely well.

What happens if HIV goes untreated

Untreated HIV moves through stages. The acute stage comes first, with a high viral load and the highest contagiousness; about 90% of people get flu-like symptoms two to four weeks after infection, right when the viral load peaks StatPearls, HIV. You can learn the warning signs of acute hiv infection, though symptoms alone can't confirm or rule it out.

Next is chronic infection, or clinical latency, where the virus stays active and slowly damages the immune system; untreated, this stage can last a decade or more. Without ART it progresses to AIDS — the most severe stage, defined by a CD4 count under 200 cells/mm³ or an opportunistic infection (a serious illness the immune system would normally fend off). Treatment changes that trajectory entirely: a 20-year-old who starts ART before their CD4 drops below 200 now has a life expectancy approaching the general population's Lancet HIV. Living with HIV also raises the risk of some other conditions, so long-term care looks at the whole person — for example, hiv positive people are at higher risk for type 2 diabetes.

Staying protected going forward

Treatment is one of the CDC's core prevention tools, alongside condoms, PrEP, PEP, and regular testing CDC, How HIV Spreads. If you're living with HIV, staying suppressed on your shots is your main contribution to prevention through U=U. For partners and for anyone HIV-negative, the table below shows how the prevention tools differ.

If you might have just been exposed and don't have HIV, PEP can prevent infection, but only if it starts within 72 hours, taken daily for 28 days. Treat it as a same-day ER or urgent-care conversation rather than a wait-and-test one CDC, PEP.

When to see a clinician

See a provider promptly if you've been diagnosed with HIV and aren't yet in care, since starting ART early is the single best thing you can do for your health. Book urgently if you have flu-like symptoms after a recent risk, because acute HIV is easy to miss and highly contagious. Go same-day for PEP if you think you were exposed in the last three days. If you're not sure of your status, you can get tested quickly, or compare testing providers to find the option that fits.